Research and Markets: Allergic Conjunctivitis - Pipeline Review, H2 2012
Research and Markets (http://www.researchandmarkets.com/research/rrpcpz/allergic) has announced the addition of the "Allergic Conjunctivitis - Pipeline Review, H2 2012" report to their offering.
This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Allergic Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Conjunctivitis.
The data is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
- A snapshot of the global therapeutic scenario for Allergic Conjunctivitis.
- A review of the Allergic Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Allergic Conjunctivitis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
Key Topics Covered:
List of Tables
List of Figures
Allergic Conjunctivitis Overview
An Overview of Pipeline Products for Allergic Conjunctivitis
Allergic Conjunctivitis Therapeutics under Development by Companies
Allergic Conjunctivitis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Mid Clinical Stage Products
Pre-Clinical Stage Products
Allergic Conjunctivitis Therapeutics - Products under Development by Companies
Allergic Conjunctivitis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Allergic Conjunctivitis Therapeutics Development
Bausch & Lomb Incorporated
Bayer HealthCare AG
Santen Pharmaceutical Co., Ltd
Sun Pharmaceutical Industries Limited
Fovea Pharmaceuticals SA
Morria Biopharmaceuticals Plc
Allergic Conjunctivitis Therapeutics - Drug Profile Updates
Allergic Conjunctivitis Therapeutics - Discontinued Products
Allergic Conjunctivitis Therapeutics - Dormant Products
Allergic Conjunctivitis - Product Development Milestones
Featured News & Press Releases
For more information visit http://www.researchandmarkets.com/research/rrpcpz/allergic.